US FDA Likely Cannot Force Sponsors To Fund Opioid Prescribing Guideline Trials

Once the National Academies of Sciences, Engineering and Medicine find conditions needing more evidence to support prescribing guidelines, the agency may have find a way to gather the data.

Young Doctor With Digital Tablet

Opioid sponsors may skirt direct involvement in the US FDA's development of evidence-based prescribing guidelines for their products.

FDA is expecting a potentially long or complicated list of conditions where further study is needed to determine optimal pain...

More from Drug Safety

More from Pink Sheet